← Open Payments lookup

WILLIAM MAYO: Open Payments

NPI 1558817809 · CLEMSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,223 in 110 payments from 21 companies in 2025. Trend: 2023 $306 · 2024 $1,429 · 2025 $2,223

Food & beverage: $2,223
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP16$553
ABBVIE INC.42$481
Otsuka America Pharmaceutical, Inc.7$168
GlaxoSmithKline, LLC.9$167
Bayer Healthcare Pharmaceuticals Inc.2$145
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$121
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$111
Axsome Therapeutics, Inc.3$87
PFIZER INC.4$85
Novartis Pharmaceuticals Corporation3$47

Products named: VRAYLAR, REXULTI, TRELEGY ELLIPTA, BREZTRI, QULIPTA, Kerendia, AIRSUPRA, FARXIGA.

Industry payments across SC — which companies pay providers there.